Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Reported or proposed issue Pregnancy, breastfeeding, children, liver disease, or cancer history Evidence source No direct human safety data Known or theoretical
We say, YOU MATTER, because you are significant
3 RGN-259 Phase 3 Trial in Neurotrophic Keratopathy Sosne et al., International Journal of Molecular Sciences (2022) This Phase 3 randomized, placebo-controlled, double-masked clinical trial evaluated topical 0.1% RGN-259 (full-length recombinant T4 ophthalmic solution) in patients with neurotrophic keratopathy
Michael Ackland Medically reviewed by Dr
![Ozempic Blood Clots Lawsuit [2026 Update]](https://www.robertkinglawfirm.com/wp-content/uploads/2024/08/how-does-ozempic-cause-blood-clots.webp)
![Wegovy Blood Clots Lawsuit [2026 Update]](https://www.robertkinglawfirm.com/wp-content/uploads/2024/09/does-wegovy-cause-blood-clots.webp)
US$ 25.62
![Can Ozempic Cause Blood Clots? [2026 Update]](https://www.robertkinglawfirm.com/wp-content/uploads/2024/08/ozempic-blood-clots-deep-vein-thrombosis-pulmonary-embolism.webp)
US$ 20.97
US$ 27.00
US$ 21.41
US$ 21.07
